WO2006039470A9
(en )
2010-01-21
Anti- amyloid antibodies, compositions, methods and uses
IN2014CN03629A
(en )
2015-09-04
WO2008002893A8
(en )
2008-10-23
Anti-amyloid antibodies, compositions, methods and uses
ZA200700351B
(en )
2008-05-28
Compounds, compositions and methods
TW200732349A
(en )
2007-09-01
Anti-OX40L antibodies and methods using same
AU2003293562A1
(en )
2004-07-22
Methods, compositions and kits for biomarker extraction
WO2007059491A8
(en )
2008-02-07
Novel hydrogels and uses thereof
TW200738751A
(en )
2007-10-16
Anti-EphrinB2 antibodies and methods using same
AU2007291030A8
(en )
2009-04-09
Novel compositions and methods
EP1854467B8
(en )
2018-09-26
Immunostimulatory composition
WO2007148309A3
(en )
2008-10-23
Compositions and kits comprising a melatonin component and a flavanol component
AU2006335053A8
(en )
2008-07-10
Novel gene disruptions, compositions and methods relating thereto
MX2007002917A
(en )
2007-07-11
All-trans-retinol : all-trans-13,14-dihydroretinol saturase and methods of its use.
AU2003902430A0
(en )
2003-06-05
Masterbatch composition
AU2007313320A1
(en )
2008-04-24
Methods and compositions for stabilizing prostate specific antigen
HK1098305A
(en )
2007-07-20
Compositions, kits, and methods utilising an added boron source
WO2007130726A3
(en )
2008-12-24
Methods for the detection of cancer
WO2007041219A3
(en )
2007-10-04
Compositions and methods for il13 biomarkers
AU2005905768A0
(en )
2005-11-03
Therapeutic methods, compositions and kits
HK1093909A
(en )
2007-03-16
An anti-hyperlipemia composition
HK1093908A
(en )
2007-03-16
An anti-hyperlipemia composition
HK1110146A
(en )
2008-07-04
Refractory solid, adhesive composition, and device, and associated method
HK1113090A
(en )
2008-09-26
Antibiotic formulations, unit doses, kits, and methods
HK1133016A
(en )
2010-03-12
Influenza antibodies, compositions, and related methods
AU2008905036A0
(en )
2008-10-16
Compositions, kits and methods